Per Sangfelt
Forskare vid Institutionen för medicinska vetenskaper; Gastroenterologi/hepatologi
- E-post:
- per.sangfelt@medsci.uu.se
- Besöksadress:
- Akademiska sjukhuset, ingång 40, 5 tr
751 85 UPPSALA - Postadress:
- Akademiska sjukhuset, ingång 40, 5 tr
751 85 UPPSALA
- Akademiska meriter:
- docent i gastroenterologi & hepatologi
Mer information visas för dig som medarbetare om du loggar in.
Publikationer
Urval av publikationer
- Monitoring Dominant Strictures in Primary Sclerosing Cholangitis with Brush Cytology and FDG-PET (2014)
- High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia (2012)
Senaste publikationer
- Placement of a transjugular intrahepatic portosystemic shunt in addition to recanalization of acute and chronic portomesenteric vein occlusions (2020)
- Mycophenolate mofetil treatment in patients with autoimmune hepatitis failing standard therapy with prednisolone and azathioprine (2019)
- Treatment of acute portomesenteric venous thrombosis with thrombectomy through a transjugular intrahepatic portosystemic shunt (2018)
- Validation of SmartPill® wireless motility capsule for gastrointestinaltransit time (2017)
- Transjugular intrahepatic portosystemic shunt treatment of variceal bleeding in an unselected patient population (2017)
Alla publikationer
Artiklar
- Placement of a transjugular intrahepatic portosystemic shunt in addition to recanalization of acute and chronic portomesenteric vein occlusions (2020)
- Mycophenolate mofetil treatment in patients with autoimmune hepatitis failing standard therapy with prednisolone and azathioprine (2019)
- Treatment of acute portomesenteric venous thrombosis with thrombectomy through a transjugular intrahepatic portosystemic shunt (2018)
- Validation of SmartPill® wireless motility capsule for gastrointestinaltransit time (2017)
- Transjugular intrahepatic portosystemic shunt treatment of variceal bleeding in an unselected patient population (2017)
- Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver (2016)
- Endovascular treatment of symptomatic Budd-Chiari syndrome - in favour of early transjugular intrahepatic portosystemic shunt. (2016)
- Active cytomegalovirus infection diagnosed by real-time PCR in patients with inflammatory bowel disease (2016)
- Hepatocellular and extrahepatic cancer in patients with autoimmune hepatitis - a long-term follow-up study in 634 Swedish patients (2015)
- Recurrence Of Psc After Liver Transplantation In The Nordic Countries (2015)
- Vanishing bile duct-like syndrome in a patient with Hodgkin lymphoma (2014)
- Monitoring Dominant Strictures in Primary Sclerosing Cholangitis with Brush Cytology and FDG-PET (2014)
- Risk For Hepatocellular Carcinoma In Autoimmune Hepatitis - Is There An Indication For Surveillance? (2013)
- Increased Fecal Levels of Chromogranin A, Chromogranin B and Secretoneurine in Collagenous Colitis (2013)
- Eosinophil associated genes in the inflammatory bowel disease 4 region (2012)
- High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia (2012)
- Fecal eosinophil cationic protein as a marker of active disease and treatment outcome in collagenous colitis (2011)
- The epidemiology and clinical features of portal vein thrombosis (2010)
- Budesonide Treatment of Patients With Collagenous Colitis Restores Normal Eosinophil and T-cell Activity in the Colon (2010)
- Characteristics and long-term outcome of patients with autoimmune hepatitis related to the initial treatment response (2010)
- Treatment of hepatitis C virus infection (2009)
- Hepatic and extrahepatic malignancies in autoimmune hepatitis. A long-term follow-up in 473 Swedish patients (2009)
- Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis (2008)
- Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease (2008)
- FBXW7/hCDC4 is a general tumor suppressor in human cancer (2007)
- Akut leversvikt - viktigt med snabb multidisciplinär handläggning (2007)
- The proinflammatory CXC-chemokines GRO-α/CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids (2007)
- Fecal levels of leukocyte markers reflect disease activity in patients with ulcerative colitis (2007)
- Autoimmune hepatitis among fertile women (2007)
- Eosinophil granulocytes are activated during the remission phase of ulcerative colitis. (2005)
- Local release of human neutrophil lipocalin (HNL), IL-8, and TNF-alpha is decreased as response to topical prednisolone treatment in distal ulcerative colitis and proctitis (2002)